Rhenman & Partners Asset Management’s Pliant Therapeutics PLRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-116,250
Closed -$1.53M 99
2024
Q4
$1.53M Sell
116,250
-4,000
-3% -$52.7K 0.16% 84
2024
Q3
$1.35M Hold
120,250
0.11% 92
2024
Q2
$1.29M Sell
120,250
-25,000
-17% -$269K 0.12% 86
2024
Q1
$2.16M Buy
145,250
+32,509
+29% +$484K 0.21% 74
2023
Q4
$2.04M Buy
+112,741
New +$2.04M 0.2% 73